Literature DB >> 831006

Antidiuretic hormone levels during cardiopulmonary bypass.

D M Philbin, C H Coggins, N Wilson, J Sokoloski.   

Abstract

The effect of CPB on plasma ADH levels, urine flow, and urine osmolality was studied in nine patients. All patients received morphine, 1 mg. per kilogram, and 50 per cent nitrous oxide-50 per cent oxygen for anesthesia. CPB utilized a Travenol disposable bubble oxygenator and the prime consisted of 3 L. of Ringer's lactate. Measurements were made prior to induction of anesthesia , at 30 minutes following surgical incision, and at 15, 30, and 45 minutes during CPB. There were no statistically significant changes in mean arterial BP, cardiac index, serum sodium, or serum osmolality in any period. Urine flow increased from 0.99 +/- 0.3 ml. per minute to a high of 6.13 +/- 2.0 ml. per minute at 30 minute at 30 minutes on CPB (P less than 0.02). Urine osmolality declined from a control value of 691 +/- 142 mOsm. per kilogram to a low of 425 +/- 48 mOsm. per kilogram at 45 minutes on CPB (p less than 0.05). ADH levels rose from a control value of 4.3 +/- 1.5 to 13.0 +/- 3.3 pg. per milliliter with surgical stimulatiion (p less than 0.05). During CPB the ADH levels rose to a peak of 23.7 +/- 3.6 pg. per milliliter at 30 minutes (p less than 0.01) and were declining at 45 minutes. These data suggest that the stress of CPB results in an outpouring of ADH (or vasopressin) to function as a pressor to produce an increase in peripheral resistance. The ADH concentrations far exceed those required for normal physiologic control of water excretion and the urineflow will thus vary more with the hemodynamic changes than with the ADH levels.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 831006

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Effect of remifentanil during cardiopulmonary bypass on incidence of acute kidney injury after cardiac surgery.

Authors:  Wataru Sakai; Yusuke Yoshikawa; Naoyuki Hirata; Michiaki Yamakage
Journal:  J Anesth       Date:  2017-10-30       Impact factor: 2.078

2.  Vasopressin and anesthesia surgery.

Authors:  W H Wu; V K Zbuzek
Journal:  Bull N Y Acad Med       Date:  1982-06

3.  Hemodynamic and hormonal responses to 8-arginine-vasopressin in healthy man: effects of indomethacin.

Authors:  K Glänzer; B Prüssing; R Düsing; H J Kramer
Journal:  Klin Wochenschr       Date:  1982-10-01

Review 4.  Effect of cardiopulmonary bypass on the pharmacokinetics of drugs.

Authors:  F O Holley; K V Ponganis; D R Stanski
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

5.  Cortisol and antidiuretic hormone responses to stress in cardiac surgical patients.

Authors:  Y Oka; S Wakayama; T Oyama; L R Orkin; R M Becker; M D Blaufox; R W Frater
Journal:  Can Anaesth Soc J       Date:  1981-07

6.  Effects of vasopressin on the circulation, myocardial dynamics, and left ventricular oxygen consumption in the anaesthetized dog.

Authors:  C F Cartheuser; J Komarek
Journal:  Basic Res Cardiol       Date:  1980 Sep-Oct       Impact factor: 17.165

7.  Plasma vasopressin levels during cardiopulmonary bypass with and without profound haemodilution.

Authors:  D M Philbin; C H Coggins
Journal:  Can Anaesth Soc J       Date:  1978-07

8.  Haemodynamic and plasma vasopressin responses with high-dose fentanyl anaesthesia during aorto-coronary bypass operations.

Authors:  L A Crone; N Wilson; J Ngsee; K W Turnbull; K Leighton
Journal:  Can Anaesth Soc J       Date:  1982-11

9.  Plasma catecholamine levels during extracorporeal circulation in children.

Authors:  M Yamashita; S Wakayama; A Matsuki; M Kudo; T Oyama
Journal:  Can Anaesth Soc J       Date:  1982-03

10.  A case of transient central diabetes insipidus after aorto-coronary bypass operation.

Authors:  Chung-Hoon Yu; Jang-Hee Cho; Hee-Yeon Jung; Jeong-Hoon Lim; Mi-Kyung Jin; Owen Kwon; Kyung-Deuk Hong; Ji-Young Choi; Se-Hee Yoon; Chan-Duck Kim; Yong-Lim Kim; Gun-Jik Kim; Sun-Hee Park
Journal:  J Korean Med Sci       Date:  2012-08-22       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.